S, S., L, F., VD, M., T, S., M, C., & S, K. (2025). Retrovirus-based manufacturing of chimeric antigen receptor-modified T cells for cancer therapy research. Methods in cell biology, 191, 329. https://doi.org/10.1016/bs.mcb.2024.10.017
Chicago Style (17th ed.) CitationS, Stock, Fertig L, Menkhoff VD, Strzalkowski T, Caruso M, and Kobold S. "Retrovirus-based Manufacturing of Chimeric Antigen Receptor-modified T Cells for Cancer Therapy Research." Methods in Cell Biology 191 (2025): 329. https://doi.org/10.1016/bs.mcb.2024.10.017.
MLA (9th ed.) CitationS, Stock, et al. "Retrovirus-based Manufacturing of Chimeric Antigen Receptor-modified T Cells for Cancer Therapy Research." Methods in Cell Biology, vol. 191, 2025, p. 329, https://doi.org/10.1016/bs.mcb.2024.10.017.